• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    Gavi enters agreement with Moderna for 500M COVID-19 vaccine doses

    The purchase agreement comes after WHO listed Moderna's COVID-19 vaccine for emergency use.

    By Jenny Lei Ravelo // 03 May 2021
    A vial of Moderna’s COVID-19 vaccine. Photo by: Governor Tom Wolf / CC BY

    Gavi, the Vaccine Alliance has signed an advance purchase agreement with Moderna for its COVID-19 vaccine, which was recently listed for emergency use by the World Health Organization.

    Sign up for Devex CheckUp

    The must-read newsletter for exclusive global health news and insider insights.

    The agreement secures 500 million doses for COVAX, with the initial supply intended for low- and middle-income countries under the global initiative’s advance market commitment. Starting in the fourth quarter of 2021, 34 million doses are expected to become available, according to a news release.

    The remaining 466 million doses are scheduled for 2022. Gavi also has options to potentially access “variant-adapted vaccine” doses in the future.

    Why it matters: There are currently limited COVID-19 vaccine options available for COVAX, which has struggled to secure supplies. A temporary export ban on doses from the Serum Institute of India, which provides COVAX with the vaccine developed by the University of Oxford and AstraZeneca, has added to supply constraints. Moderna has received funding from the Coalition for Epidemic Preparedness Innovations for its vaccine and has been expected to contribute to COVAX.

    • Global Health
    • Private Sector
    • WHO
    • Moderna
    • Gavi
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Global healthHow Gavi is reaching ‘zero-dose’ children in conflict areas

    How Gavi is reaching ‘zero-dose’ children in conflict areas

    Global HealthRobert F. Kennedy Jr. says the US is cutting funding for Gavi

    Robert F. Kennedy Jr. says the US is cutting funding for Gavi

    The Future of US AidThe USAID awards the Trump administration killed — and kept

    The USAID awards the Trump administration killed — and kept

    Global HealthSeth Berkley warns of an era of ‘polyepidemics’ as cooperation crumbles

    Seth Berkley warns of an era of ‘polyepidemics’ as cooperation crumbles

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      The UN's changing of the guard
    • 4
      Opinion: Urgent action is needed to close the mobile gender gap
    • 5
      The top local employers in Europe
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement